000281778 001__ 281778
000281778 005__ 20251014154610.0
000281778 0247_ $$2doi$$a10.1093/braincomms/fcaf366
000281778 0247_ $$2pmid$$apmid:41079753
000281778 0247_ $$2pmc$$apmc:PMC12508649
000281778 037__ $$aDZNE-2025-01173
000281778 041__ $$aEnglish
000281778 082__ $$a610
000281778 1001_ $$0P:(DE-2719)9001926$$aDadsena, Ravi$$b0$$udzne
000281778 245__ $$aEvidence of clinical and brain recovery in post-COVID-19 condition: a three-year follow-up study.
000281778 260__ $$a[Oxford]$$bOxford University Press$$c2025
000281778 3367_ $$2DRIVER$$aarticle
000281778 3367_ $$2DataCite$$aOutput Types/Journal article
000281778 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1760449471_29927
000281778 3367_ $$2BibTeX$$aARTICLE
000281778 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000281778 3367_ $$00$$2EndNote$$aJournal Article
000281778 520__ $$aFatigue and cognitive dysfunction linked to persistent brain changes have been reported for up to two years after COVID-19. In this study, we followed the clinical, neuroimaging and fluid biomarker trajectories over three years post SARS-CoV-2 infection to evaluate potential signs and underlying factors of brain recovery. We conducted a monocentric, longitudinal study using resting-state functional and structural T1-weighted magnetic resonance imaging data from 51 patients with post-COVID-19 condition (mean age 50 years, 33 female) collected at a mean time of 6, 23 and 38 months after COVID-19 infection. The trajectory of brain changes was compared to 23 age- and sex-matched healthy controls (mean age 37 years, 13 female) with similar time intervals between brain scans and analysed in relation to clinical, neuropsychological and fluid biomarkers including interleukins and neurodestruction markers at all timepoints. In addition, hand grip strength to evaluate muscular fatigue was assessed at the final follow-up visit. Self-reported fatigue improved over time but was still moderate on average three years after COVID-19 infection, while measures of hand grip strength and cognitive performance were largely unaffected. We found a significant increase of both lateral ventricles (∼8%) and the third (∼6%) ventricle accompanied by a structural volume reduction in adjacent areas including the thalamus, pallidum, caudate nucleus and putamen. An increased neuronal activation pattern was widespread and pronounced in these areas. The brainstem no longer exhibited volume loss as reported in our pervious study, but enhanced functional connectivity. Laboratory markers including interleukins and neuronal injury markers remained within the normal reference ranges across all study timepoints. Our study revealed an overall slow but evident clinical improvement, including improved fatigue, regular muscular strength and recovery as well as normal cognitive function without signs of systemic inflammation three years after COVID-19. Clinical improvement is reflected by a pattern of brain recovery along periventricular regions. This pattern is characterized by structural stabilization and increased connectivity starting in the brainstem as well as efficient neuronal recruitment and increased activation in the basal ganglia, with no evidence of neuronal injury. These results highlight the positive long-term recovery trajectory in post-COVID patients.
000281778 536__ $$0G:(DE-HGF)POF4-352$$a352 - Disease Mechanisms (POF4-352)$$cPOF4-352$$fPOF IV$$x0
000281778 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000281778 650_7 $$2Other$$aALFF
000281778 650_7 $$2Other$$aCNS
000281778 650_7 $$2Other$$aMRI
000281778 650_7 $$2Other$$afatigue
000281778 650_7 $$2Other$$along COVID
000281778 7001_ $$aWetz, Sophie$$b1
000281778 7001_ $$0P:(DE-2719)2814244$$aHofmann, Anna$$b2$$udzne
000281778 7001_ $$00000-0002-1999-6616$$aCosta, Ana Sofia$$b3
000281778 7001_ $$aRomanzetti, Sandro$$b4
000281778 7001_ $$aLischewski, Stella Andrea$$b5
000281778 7001_ $$aKrockauer, Christina$$b6
000281778 7001_ $$aBalloff, Carolin$$b7
000281778 7001_ $$00000-0002-6750-943X$$aBinkofski, Ferdinand$$b8
000281778 7001_ $$aSchulz, Jörg B$$b9
000281778 7001_ $$00000-0002-9730-9228$$aReetz, Kathrin$$b10
000281778 7001_ $$aWalders, Julia$$b11
000281778 773__ $$0PERI:(DE-600)3020013-1$$a10.1093/braincomms/fcaf366$$gVol. 7, no. 5, p. fcaf366$$n5$$pfcaf366$$tBrain communications$$v7$$x2632-1297$$y2025
000281778 8564_ $$uhttps://pub.dzne.de/record/281778/files/DZNE-2025-01173.pdf$$yRestricted
000281778 8564_ $$uhttps://pub.dzne.de/record/281778/files/DZNE-2025-01173.pdf?subformat=pdfa$$xpdfa$$yRestricted
000281778 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)9001926$$aExternal Institute$$b0$$kExtern
000281778 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2814244$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b2$$kDZNE
000281778 9131_ $$0G:(DE-HGF)POF4-352$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vDisease Mechanisms$$x0
000281778 9141_ $$y2025
000281778 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBRAIN COMMUN : 2022$$d2024-12-20
000281778 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-20
000281778 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-20
000281778 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-04-03T10:36:45Z
000281778 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-04-03T10:36:45Z
000281778 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2024-04-03T10:36:45Z
000281778 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2024-04-03T10:36:45Z
000281778 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-20
000281778 915__ $$0StatID:(DE-HGF)0112$$2StatID$$aWoS$$bEmerging Sources Citation Index$$d2024-12-20
000281778 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-20
000281778 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-20
000281778 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-20
000281778 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-20
000281778 9201_ $$0I:(DE-2719)1210001$$kAG Jucker$$lCell Biology of Neurological Diseases$$x0
000281778 980__ $$ajournal
000281778 980__ $$aEDITORS
000281778 980__ $$aVDBINPRINT
000281778 980__ $$aI:(DE-2719)1210001
000281778 980__ $$aUNRESTRICTED